Compounds > fluconazole

fluconazole and oxiconazole

fluconazole has been researched along with oxiconazole in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bertini, S; Herreros, E; Lapucci, A; Macchia, B; Macchia, M; Martinelli, A; Rapposelli, S; Rossello, A1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bhandari, K; Shiva Keshava, GB; Shukla, PK; Srinivas, N1
Mani Chandrika, KVS; Sharma, S1
Benko, I; Hernádi, F; Kiss, A; Kovács, P; Kraicsovits, F; Megyeri, A; Somogyi, G; Tegyey, Z1
Ishida, S; Matsui, H; Nishimura, Y; Okano, Y; Oyama, TB; Oyama, TM; Oyama, Y; Sakanashi, Y; Yokota, S1

Reviews

1 review(s) available for fluconazole and oxiconazole

ArticleYear
Promising antifungal agents: A minireview.
    Bioorganic & medicinal chemistry, 2020, 04-01, Volume: 28, Issue:7

    Topics: Antifungal Agents; Drug Design; Fungi; Humans; Molecular Structure; Mycoses; Structure-Activity Relationship

2020

Other Studies

5 other study(ies) available for fluconazole and oxiconazole

ArticleYear
Synthesis, antifungal activity, and molecular modeling studies of new inverted oxime ethers of oxiconazole.
    Journal of medicinal chemistry, 2002, Oct-24, Volume: 45, Issue:22

    Topics: Antifungal Agents; Aspergillus fumigatus; Candida; Cryptococcus neoformans; Cytochrome P-450 Enzyme System; Ethers; Imidazoles; Microbial Sensitivity Tests; Models, Molecular; Oxidoreductases; Oximes; Recombinant Fusion Proteins; Sterol 14-Demethylase; Structure-Activity Relationship; Trichophyton

2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:1

    Topics: Anti-Bacterial Agents; Azoles; Bacteria; Escherichia coli; Ethers; Imidazoles; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Conformation; Naphthalenes; Oximes; Staphylococcus aureus; Structure-Activity Relationship

2009
Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Animals; Antifungal Agents; Azoles; Bone Marrow; Cells, Cultured; Clotrimazole; Dose-Response Relationship, Drug; Econazole; Female; Fluconazole; Granulocytes; Hematopoietic Stem Cells; Humans; Imidazoles; Inhibitory Concentration 50; Ketoconazole; Macrophages; Male; Mice; Miconazole; Species Specificity; Stem Cells

1999
Imidazole antifungals, but not triazole antifungals, increase membrane Zn2+ permeability in rat thymocytes Possible contribution to their cytotoxicity.
    Toxicology, 2008, Jun-27, Volume: 248, Issue:2-3

    Topics: Animals; Antifungal Agents; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Chlorides; Clotrimazole; Dose-Response Relationship, Drug; Fluconazole; Imidazoles; Itraconazole; Male; Rats; Rats, Wistar; Structure-Activity Relationship; T-Lymphocytes; Thymus Gland; Triazoles; Zinc Compounds

2008